| Income Statement |
| Total Revenue | 144.70M |
|
| Revenues (USD) | 144.70M |
| Cost of Revenue | 98.50M |
| Gross Profit | 46.20M |
| Operating Expenses | 34.60M |
| Research and Development Expense | 10.10M |
| Selling, General and Administrative Expense | 24.50M |
| Operating Income | 11.60M |
| Interest Expense | 600.00K |
| Income Tax Expense | 900.00K |
| Net Income | 10.10M |
| Net Income Common Stock | 10.10M |
| Net Income Common Stock (USD) | 10.10M |
| Consolidated Income | 10.10M |
| Earnings per Basic Share | 0.38 |
| Earnings per Basic Share (USD) | 0.38 |
| Earnings per Diluted Share | 0.38 |
| Earning Before Interest & Taxes (EBIT) | 11.60M |
| Earning Before Interest & Taxes (USD) | 11.60M |
| Weighted Average Shares | 26.20M |
| Weighted Average Shares Diluted | 26.55M |
| Balance Sheet |
| Cash and Equivalents | 271.60M |
| Cash and Equivalents (USD) | 271.60M |
| Investments | 498.00M |
| Trade and Non-Trade Receivables | 957.40M |
| Total Assets | 2.32B |
| Total Liabilities | 1.85B |
| Accumulated Retained Earnings (Deficit) | -1.20B |
| Accumulated Other Comprehensive Income | -2.00M |
| Shareholders Equity | 465.60M |
| Shareholders Equity (USD) | 465.60M |
| Deferred Revenue | 741.00M |
| Goodwill and Intangible Assets | 55.00M |
| Trade and Non-Trade Payables | 396.30M |
| Cash Flow |
| Net Cash Flow from Financing | 900.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -33.20M |
| Capital Expenditure | -3.30M |
| Issuance (Purchase) of Equity Shares | 1.10M |
| Net Cash Flow from Investing | -77.20M |
| Net Cash Flow - Investment Acquisitions and Disposals | -73.90M |
| Net Cash Flow from Operations | 43.10M |